Stanford Medicine scientists devised a cancer imaging technology that opens doors to new research questions and precision medicine.
Researchers at Stanford Medicine investigate cancer disparities in LGBTQ populations and how to address them.
A group of Black women work toward a peer navigation program to help other Black women survive breast cancer.
Stanford Medicine magazine explores the molecules behind human biology and how understanding them fuels medical discoveries and innovations.
Ovarian cancer genetic testing is underused and large gene panels lead to uncertain results, particularly for non-white patients, a Stanford Medicine study finds.
Stanford stem cell biologists have found a way to block a signal that causes growth of breast cancer cells, opening potential for new treatments.
In breast and lung cancer patients with metastatic disease, seeds of metastasis were often planted before the primary tumor was diagnosed, a study finds.
The experts on Stanford Medicine's molecular tumor board brainstorm new ways to attack individual patients' tumors at the genetic level.
In this episode of "The Future of Everything," host Russ Altman and guest Ross Shachter discuss how AI can help radiologists with diagnosis accuracy.
Surgeon Irene Wapnir and her colleagues developed a new technique for creating biological breast implants for women who have undergone a mastectomy.
This In the Spotlight features Helio Costa, a geneticist who has developed an assay currently being used to help cancer patients.
Stanford researchers develop a machine-learning computer model for mammography assessment in hopes of aiding radiologists’ clinical decisions.
Stanford researchers make progress in predicting which patients will suffer heart problems from chemotherapy, and may have found a drug to mitigate them.
Molecular data identifies breast cancer subgroups likely to recur decades after successful treatment, predicts probable timing and location of metastases.
Stanford researchers have learned that cancer cells can batter their way into new territory, rather than relying on dissolving chemicals.
Mapping the geography of the immune response in triple negative breast cancers predicts patient survival and sheds light onto new aspects of tumor biology.
